SCHEMBL13044014

SCHEMBL13044014

CCCCOc1c(Br)cc(C)cc1-c1cc(C)cc(C)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRA P10827 4/20 0.44
THRB P10828 4/20 0.44
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
POLB P06746 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MCL1 Q07820 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13044016 0.87 MAPT (0.48) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL13044404 0.86 THRA (0.39) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL12833107 0.84 THRA (0.57) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL12440958 0.80 MAPT (0.59) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL13044013 0.79 MAPT (0.46) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL13044026 0.77 MAPT (0.56) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL13510084 0.77 MAPT (0.44) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL13429866 0.77 THRA (0.46) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL16330286 0.77 THRA (0.50) THRATHRBMAPTL3MBTL1ALDH1A1
SCHEMBL3315111 0.74 THRA (0.48) THRATHRBMAPTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501840-B1 BRIDGED BI-AROMATIC LIGANDS, COMPLEXES, CATALYSTS, PROCESSES FOR POLYMERIZING AND POLYMERS THEREFROM SYMYX SOLUTIONS INC (US) 2010-12-22 EP disclosed
US-7659415-B2 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom SYMYX SOLUTIONS, INC. (US) 2010-02-09 US disclosed
US-20080269470-A1 Bridged Bi-Aromatic Ligands, Catalysts, Processes For Polymerizing And Polymers Therefrom SYMYX TECHNOLOGIES, INC. (US) 2008-10-30 US disclosed
US-7241715-B2 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom SYMYX TECHNOLOGIES, INC. (US) 2007-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269470-A1 Bridged Bi-Aromatic Ligands, Catalysts, Processes For Polymerizing And Polymers Therefrom WEE1, WASF2, WEE2 THRA 3478/4885THRB 3204/4885MAPT 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.